Welcome to our dedicated page for Genworth Finl SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Genworth Financial, Inc. (NYSE: GNW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, annual reports, and quarterly reports filed with the U.S. Securities and Exchange Commission. As a publicly traded holding company with operations in long-term care insurance, life and annuities, and U.S. mortgage insurance through Enact Holdings, Inc. (Nasdaq: ACT), Genworth uses these filings to present detailed financial and segment information.
Investors reviewing GNW SEC filings can examine how Genworth reports results for its Enact, Long-Term Care Insurance, and Life and Annuities segments, along with holding company activities. Filings such as Form 10-K and Form 10-Q typically include discussions of net income, adjusted operating income, segment performance, investment results, statutory capital measures, and risk-based capital ratios for U.S. life insurance subsidiaries. They also describe Genworth’s use of non-GAAP measures, including how adjusted operating income is defined and reconciled to GAAP net income.
Current reports on Form 8-K, such as the filing dated November 5, 2025, document material events including the release of quarterly financial results and the availability of related press releases and financial supplements. These filings often reference exhibits that contain detailed data tables and segment disclosures.
Through Stock Titan, users can follow GNW filings in real time as they are posted to the SEC’s EDGAR system. AI-powered tools summarize lengthy documents, highlight key themes such as capital allocation, share repurchase authorizations, segment trends, and legal or regulatory updates, and help clarify the implications of complex items like liability remeasurement in long-term care, reserve releases in mortgage insurance, or changes in market risk benefits. The filings page can also surface insider transaction reports on Form 4 and proxy-related disclosures when available, giving a fuller view of executive and governance-related information.
Genworth Financial Inc. reported an insider stock transaction by its President and CEO, who is also a director. On December 2, 2025, the reporting person sold 40,000 shares of Genworth common stock at a price of $8.64 per share. After this sale, the reporting person beneficially owned 5,107,444 shares directly and 89,456 shares indirectly through trusts for the benefit of his children.
The filing notes that earlier in the year, on May 30, 2025, a grantor retained annuity trust (GRAT) terminated, resulting in 419,534 shares moving into the reporting person’s direct ownership and 89,456 shares being transferred to children’s trusts. The form also allows for the indication that the transaction may have been made under a pre-arranged Rule 10b5-1 trading plan.
Genworth Financial (GNW) insider plans Rule 144 sale after stock vesting. A holder has filed to sell 40,000 shares of GNW common stock through Fidelity Brokerage Services on the NYSE, with an indicated aggregate market value of $345,600. The filing shows that these shares were acquired on 03/03/2025 via restricted stock vesting from the issuer as compensation. As of the filing, 399,380,567 shares of GNW common stock were outstanding, providing context for the size of the planned sale.
Genworth Financial (GNW) executive David F. Kurzawa, EVP and General Counsel, reported a stock sale in a Form 4 filing. On 11/24/2025, he sold 40,000 shares of Genworth common stock at a weighted average price of $8.5101 per share through a series of broker-assisted transactions within a price range of $8.51 to $8.54 per share.
After this transaction, he beneficially owned 302,000 shares of Genworth common stock directly, plus 4,746.438 shares held indirectly through a 401(k) plan. The filing notes that detailed trade breakdowns within the reported price range are available upon request from the reporting person.
Genworth Financial (GNW) filed a Form 4 reporting that its EVP and Chief HR Officer made a charitable gift of company stock. On 11/10/2025, the insider transferred 3,513 shares of Common Stock, coded “G” for gift, at a reported price of $0.
After this transaction, the insider beneficially owns 133,571 shares, listed as direct ownership. The footnote states the shares were gifted to a charitable organization.
Genworth Financial (GNW) received a Schedule 13G from Donald Smith & Co., Inc. and DSCO Value Fund, L.P. reporting beneficial ownership of 24,976,084 shares of GNW common stock, equal to 6.09% of the class, tied to an event date of September 30, 2025.
The filers certify the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Donald Smith & Co., Inc. files as an investment adviser, with economic rights to dividends and sale proceeds residing with its clients. To its knowledge, no single client holds more than 5% of Genworth’s outstanding common stock.
Genworth Financial, Inc. (GNW) furnished its quarterly materials. The company provided a press release and a financial supplement covering results for the quarter ended September 30, 2025, as Exhibits 99.1 and 99.2.
The information was furnished, not filed, under the Exchange Act and is not subject to Section 18 liabilities, nor incorporated by reference into other filings unless expressly stated.
Genworth Financial insider transaction: Rohit Gupta, identified as an officer (President & CEO, Enact) of Genworth Financial, sold 86,406 shares of Genworth common stock on 08/27/2025 at a weighted average sales price of $8.6784 per share. After the sale, Mr. Gupta directly beneficially owned 794,630 shares. In addition, 7,054.809 shares are reported as indirectly owned via a 401(k) plan. The Form 4 was signed by a power of attorney on 08/29/2025. The filer discloses the sale price range ($8.67 to $8.69) and offers to provide a detailed allocation of shares sold at each price on request.